Septerna, Inc. Share Price

Septerna, Inc. Share Price

NASDAQ: SEPN | Small Cap
$45.17
+$1.06 (2.40%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Septerna, Inc. Stock Performance

Open
$43.85
Prev. Close
$44.11
Circuit Range
N/A
Day Range
$43.85 - $45.35
Year Range
$17.73 - $51.10
Volume
9,413
Average Traded
$45.04

Septerna, Inc. Share Price Today

As of 30 October 2026, Septerna, Inc.'s share price is $45.17. The stock opened at $43.85, compared to its previous close of $44.11. During today's trading session, Septerna, Inc.'s share price traded between $43.85 and $45.35, with an average price of $44.60. Over the past 52 weeks, the stock has recorded a high of $51.10 and a low of $17.73. In terms of performance, Septerna, Inc.'s share price has risen by 90.07% over the last six months and is up 119.54% on a year-on-year basis.

Septerna, Inc. Share Price Chart

Line chart of the Septerna, Inc. price trend over the selected period. The price rose overall, ranging from 43.85 to 45.48, ending at 45.17.
$43.85$45.35
L
Show Current Price
H

Septerna, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.00B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.52
Revenue (TTM)
$45.95B
Return On Equity (TTM)
-6.27%
Profit Margin
-106.38%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-259.49%

Septerna, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$21.50$24.12$26.52$26.75
Net Profit$8.17-$10.74-$8.64-$13.03
Net Profit Margin38.00%-44.53%-32.58%-48.71%
Income ChangeN/A-231.46%19.55%-50.81%

Septerna, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$1.08$45.95
Net Profit-$71.80-$48.88
Net Profit Margin-6648.15%-106.38%
Income ChangeN/A31.92%

About Septerna, Inc.

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

Septerna, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$39.25
$45.23
+15.49%
Sep 2026
$37.68
$39.16
-3.00%
Aug 2026
$34.49
$40.37
+17.24%
Jul 2026
$33.45
$34.44
+2.65%
Jun 2026
$29.36
$33.55
+11.08%
May 2026
$23.93
$30.20
+27.08%
Apr 2026
$24.61
$23.77
-0.98%
Mar 2026
$28.01
$24.00
-17.27%
Feb 2026
$23.21
$29.01
+24.29%
Jan 2026
$28.30
$23.34
-15.91%
Dec 2025
$28.98
$27.75
-4.29%
Nov 2025
$20.71
$29.00
+40.95%

SEPN Share Price FAQs